A Randomized Controlled Study on the Effect of MRJPs on Improving Ovarian Function and Endometrial Receptivity

NCT07246733 · tracked via the Priya Life Science China tracker

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Phase

Not applicable

Started

2025-07-01

Last updated

2025-11-24

Condition(s) studied

Diminished Ovarian Reserve (DOR)Thin Endometrium

Investigational drug(s) / intervention(s)

Oral MRJPs CandyOral placebo candy

Oral MRJPs Candy: 500 mg per tablet, containing 70% MRJPs freeze-dried powder + 20% sodium cellulose + 10% microcrystalline cellulose, with an appropriate amount of arabinose, taken twice a day, 1 tablet each time, for a total of 1 menstrual cycle in the control group.

Oral placebo candy: 500 mg per tablet, containing 70% whey protein powder + 20% sodium cellulose + 10% microcrystalline cellulose, with appropriate amount of arabinose, taken twice a day, 1 tablet each time, for a total of 1 menstrual cycle in the control group.

Study summary

This study will assess the effects of the rose tablet candies produced by MRJPs on the subjects, evaluate the role of MRJPs in the ovarian function and endometrial receptivity of women, reveal the potential application value of MRJPs in reproductive health, and determine its safety and effectiveness.

Eligibility

Sex

FEMALE

Min age

20 Years

Max age

45 Years

Healthy volunteers

Accepted

Inclusion Criteria: * Fertile women, aged 20 to 45 years old, with regular and normal menstrual cycles. Exclusion Criteria: * ① Allergic to royal jelly or its components; ② Suffering from severe chronic diseases or endocrine system disorders; ③ Pregnant or breastfeeding; ④ Undergoing hormone replacement therapy (HRT) within the last month

Primary outcome measure(s)

Anti-Müllerian hormone — From enrollment to the end of treatment at 1 month
Ovarian function testing indicator

Trial sites (1)

Facility	City	Region	Status
The Fourth Affiliated Hospital of Zhejiang University School of Medicine	Yiwu	Zhejiang	Recruiting

More The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials in China

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea Recruiting

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy Recruiting

The Preventive and Therapeutic Effects of Spirulina Preparations on Ulcers of Oral Mucosa Recruiting

The Clinical Research of Traditional Chinese Medicine Compound Formulas Starting soon

Artificial Intelligence in Detecting Cardiac Function Enrolling by invitation

Other trials for the same condition

Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve Starting soon

Multi-Site Cortical Puncture for DOR Starting soon

Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy Starting soon

RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET Starting soon

Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07246733 on ClinicalTrials.gov ↗ ← All trials in China